VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 143 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 2.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6,843,896 | +38.4% | 1,211,309 | +0.7% | 0.00% | – |
Q1 2024 | $4,945,542 | -4.6% | 1,203,295 | -2.0% | 0.00% | – |
Q4 2023 | $5,182,565 | -8.0% | 1,228,096 | -5.8% | 0.00% | – |
Q3 2023 | $5,632,334 | -79.1% | 1,303,781 | -68.0% | 0.00% | -100.0% |
Q2 2023 | $26,891,391 | -13.0% | 4,080,636 | -10.4% | 0.00% | -50.0% |
Q1 2023 | $30,907,482 | -43.9% | 4,551,912 | -38.9% | 0.00% | 0.0% |
Q4 2022 | $55,096,854 | +51.3% | 7,455,596 | +102.3% | 0.00% | 0.0% |
Q3 2022 | $36,411,000 | -10.1% | 3,685,351 | -0.8% | 0.00% | 0.0% |
Q2 2022 | $40,504,000 | -11.9% | 3,715,925 | -8.5% | 0.00% | 0.0% |
Q1 2022 | $45,956,000 | -12.0% | 4,063,298 | +22.1% | 0.00% | 0.0% |
Q4 2021 | $52,207,000 | -10.4% | 3,327,433 | -2.1% | 0.00% | -33.3% |
Q3 2021 | $58,242,000 | -14.4% | 3,398,042 | +7.5% | 0.00% | -25.0% |
Q2 2021 | $68,004,000 | +36.7% | 3,161,509 | -4.6% | 0.00% | +33.3% |
Q1 2021 | $49,751,000 | +18.2% | 3,312,339 | +3.4% | 0.00% | 0.0% |
Q4 2020 | $42,099,000 | +28.7% | 3,203,904 | -5.4% | 0.00% | +50.0% |
Q3 2020 | $32,702,000 | -22.3% | 3,385,334 | -8.0% | 0.00% | -33.3% |
Q2 2020 | $42,083,000 | +43.2% | 3,678,612 | +29.7% | 0.00% | 0.0% |
Q1 2020 | $29,380,000 | -29.3% | 2,835,916 | +11.9% | 0.00% | 0.0% |
Q4 2019 | $41,583,000 | +9.3% | 2,534,020 | -11.6% | 0.00% | 0.0% |
Q3 2019 | $38,058,000 | -10.0% | 2,865,837 | -4.5% | 0.00% | 0.0% |
Q2 2019 | $42,281,000 | -37.4% | 3,000,816 | -18.3% | 0.00% | -40.0% |
Q1 2019 | $67,580,000 | +4.6% | 3,672,809 | +48.6% | 0.01% | -16.7% |
Q4 2018 | $64,592,000 | +11.2% | 2,471,955 | -2.4% | 0.01% | +50.0% |
Q3 2018 | $58,100,000 | +40.3% | 2,531,741 | +16.5% | 0.00% | +33.3% |
Q2 2018 | $41,399,000 | +30.4% | 2,173,011 | +15.3% | 0.00% | 0.0% |
Q1 2018 | $31,747,000 | -2.2% | 1,884,090 | -11.8% | 0.00% | 0.0% |
Q4 2017 | $32,456,000 | +10.0% | 2,135,227 | +29.5% | 0.00% | 0.0% |
Q3 2017 | $29,507,000 | +11.9% | 1,648,632 | +1.9% | 0.00% | +50.0% |
Q2 2017 | $26,380,000 | +19.9% | 1,618,485 | +2.9% | 0.00% | 0.0% |
Q1 2017 | $22,007,000 | -21.2% | 1,572,186 | -10.2% | 0.00% | -33.3% |
Q4 2016 | $27,935,000 | +21.9% | 1,751,605 | +27.2% | 0.00% | +50.0% |
Q3 2016 | $22,921,000 | +59.3% | 1,377,510 | +7.2% | 0.00% | 0.0% |
Q2 2016 | $14,385,000 | +15.6% | 1,285,054 | -13.7% | 0.00% | +100.0% |
Q1 2016 | $12,442,000 | -20.9% | 1,488,367 | -11.9% | 0.00% | -50.0% |
Q4 2015 | $15,721,000 | -44.0% | 1,688,766 | -32.1% | 0.00% | -33.3% |
Q3 2015 | $28,066,000 | -13.9% | 2,488,179 | -3.2% | 0.00% | 0.0% |
Q2 2015 | $32,610,000 | +30.6% | 2,569,617 | -4.3% | 0.00% | 0.0% |
Q1 2015 | $24,974,000 | -7.1% | 2,685,595 | +43.0% | 0.00% | 0.0% |
Q4 2014 | $26,888,000 | +42.9% | 1,877,584 | +3.6% | 0.00% | +50.0% |
Q3 2014 | $18,811,000 | -25.1% | 1,812,334 | +16.8% | 0.00% | -33.3% |
Q2 2014 | $25,110,000 | -0.6% | 1,551,918 | -0.2% | 0.00% | 0.0% |
Q1 2014 | $25,262,000 | +180.9% | 1,554,430 | +41.5% | 0.00% | +200.0% |
Q4 2013 | $8,994,000 | +56.1% | 1,098,628 | +109.3% | 0.00% | 0.0% |
Q3 2013 | $5,762,000 | +39.7% | 524,832 | +2.8% | 0.00% | 0.0% |
Q2 2013 | $4,125,000 | – | 510,518 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |